Glydo

Glydo is a prescription medication containing lidocaine hydrochloride as the active ingredient. It is formulated for urethral administration and is marketed in the European Union. The product is classified as a local anesthetic and is intended to provide temporary numbing of the urethral mucosa for diagnostic or therapeutic procedures. Glydo is supplied in a sterile preparation suitable for urethral use under strict aseptic conditions as required.

Glydo is indicated for urethral anesthesia in adult patients undergoing procedures that require temporary loss of sensation in the urethra.

- Diagnostic cystoscopy - Urethral catheter insertion - Endoscopic urethral surgery - Urethral dilation - Post‑procedure discomfort management

Adverse reactions to Glydo are generally mild and related to its local anesthetic properties, but rare serious events can occur.

Common: - Transient burning or stinging at the application site - Mild urethral irritation - Temporary urinary urgency

Serious: - Allergic reaction such as rash or angio‑edema - Cardiovascular effects like hypotension - Central nervous system symptoms such as seizures

Before using Glydo, clinicians should evaluate patient history and procedural factors to minimize risks associated with local anesthetic use.

- Assess for known hypersensitivity to lidocaine or amide‑type anesthetics - Use the lowest effective dose for the shortest duration - Avoid use in patients with severe cardiac conduction disorders - Do not exceed recommended volume for urethral administration - Monitor patients for signs of systemic toxicity, especially after prolonged procedures - Consider alternative anesthesia in pregnant or lactating women when safety is uncertain

Lidocaine can interact with other medications that affect cardiac conduction or hepatic metabolism, so potential drug interactions should be reviewed before prescribing Glydo.

Avoid: - Concurrent use of Class I anti‑arrhythmic agents (e.g., quinidine, procainamide) - Strong CYP3A4 inhibitors such as ketoconazole or erythromycin - Other local anesthetics administered at the same time

Use with caution: - Beta‑blockers or calcium‑channel blockers that may enhance cardiac effects - Drugs that lower seizure threshold (e.g., tramadol, bupropion) - Moderate CYP3A4 inducers (e.g., carbamazepine) that may reduce lidocaine levels